Associate Pricing & Planning Director

Job Overview

The Associate Director, Pricing, Forecasting, and Contracting is responsible for leading pricing strategy, payer and channel contracting analytics, gross-to-net decision support, contract rebate bid modeling, and for supporting brand forecasting for Amneal's Specialty Medicine portfolio. This Market Access role serves as a strategic partner to customer‑facing Account Directors, Market Access leadership, Finance, Gross‑to‑Net Team, Commercial Operations and Analytics, and Sales to develop pricing and contracting strategies that optimize access, revenue, profitability, and long‑term brand performance.

This individual will report to the Senior Director, Pricing, Forecasting, and Contracting and support development of launch Wholesale Acquisition Cost (WAC) recommendations and annual price action analyses and will individually lead payer bid and contract modeling, and ongoing contract performance analysis for all branded specialty medicines. The role requires deep expertise in specialty pharmaceutical pricing and reimbursement dynamics, including AMP, ASP, 340B, URA, IRA implications, price protection, rebate economics, and government pricing sensitivity.

The individual must be able to translate complex data from plan‑level utilization sources, payer invoice detail, and third‑party market data into clear, actionable recommendations for senior leadership. The ideal candidate is a highly strategic and fiercely analytical pricing leader with deep branded specialty experience, strong business judgment, and the ability to connect detailed quantitative analysis to broader portfolio, access, and brand strategy.

• Serve as the analytical lead for commercial payer and other strategic contract opportunities, developing bid models and contract recommendations that balance expected brand growth, access improvement, and net revenue impact; calculate break‑even and return‑on‑contract scenarios by incorporating rebate levels, expected utilization changes, formulary access assumptions, channel dynamics, and projected brand growth; evaluate payer proposals and contract offers using plan‑level utilization data, historical claims or invoice‑based utilization patterns, competitive context, and anticipated market‑share impact;
  
  develop customer‑ and segment‑specific value/rebate frameworks to support strategic decision‑making across Commercial, Medicare Part D, Medicaid, 340B, GPO, LTC, VA/DoD, specialty pharmacy, and other relevant channels; present pricing and contracting recommendations to senior leadership with clear articulation of risks, tradeoffs, and strategic implications; support customer‑facing Market Access account directors by providing clear compelling bid modeling designed to win business and create access while maintaining profitability and aligning to long‑term revenue objectives.
• Provide strategic guidance on pricing and contracting decisions by assessing implications for AMP, ASP, 340B, URA, Best Price sensitivity, IRA‑related considerations, and price protection exposure; partner with GTN, Finance, and Government Pricing stakeholders to evaluate the downstream effects of pricing actions, launch assumptions, rebate strategies, and contract structures on net revenue and compliance‑sensitive calculations; support quarterly accrual processes and ongoing GTN forecasting by maintaining accurate assumptions for rebates, fees, discounts, utilization, and customer mix;
  
  identify and communicate pricing and contracting risks associated with government reporting, reimbursement, and policy changes; help ensure analytics and recommendations are grounded in a practical understanding of operational feasibility, reporting requirements, and compliance constraints.
• Lead development of short‑ and long‑term pricing strategies for in‑line and pipeline specialty brands; develop launch pricing recommendations, including establishment of WAC, scenario modeling, analog assessment, competitive benchmarking, and evaluation of access, reimbursement, and GTN implications; support annual price action analyses, including list price change recommendations, scenario assessment, financial impact…